Additional benefits include significant improvement in the physical and mental states of people with alcohol use disorder
Prescription of GIP/GLP-1 RA linked to lower rates of opioid overdose and alcohol intoxication
Higher binge-drinking prevalence reported by race, ethnicity-defined subgroups
Patients treated with antidepressants whose symptoms do not improve show more relapses in alcohol use disorder
Findings show risk cut in half based on electronic health record data
Reduction seen in incidence of composite outcome of all-cause mortality, return to hospital with MAUD initiation at discharge
Findings show similarly increased risk in men and women based on pooled odds ratio from longitudinal studies
Multidisciplinary integrated care model with hepatology, addiction medicine providers, social workers should be promoted
Multidisciplinary integrated care model with hepatology, addiction medicine providers, social workers should be promoted
Strongest demographic predictor for discharge initiation of medications for alcohol use disorder was younger age